-
21. Cannabis Research Past, Present, & Future with Raphael Mechoulam, PhD
Our latest guest is Professor Raphael Mechoulam. Professor Mechoulam is the first researcher to isolate THC and CBD. For that achievement and the decades of research into the endocannabinoid system that followed, Professor Mechoulam is often called the “Godfather of cannabis research”.
Since his research began in the 1960s, Professor Mechoulam has received numerous academic awards. Most recently he received The Harvey Prize from the Technion Israel Institute of Technology in the Human Health category. It’s a pretty big deal when you consider more than 30% of Harvey laureates since 1986 have gone onto receive the Nobel prize.
Professor Mechoulam has presented at every CannMed event, either in person or via submitted video, and is the chair of our Scientific Advisory Board.
In our conv...
published: 03 Feb 2021
-
Functional Forum Interview: Medical Cannabis with Dr. Raphael Mechoulam
Register to watch next the Functional Forum: http://functionalforum.com/next-event
Subscribe: https://bit.ly/2n9QpsC
Practitioners - Join the EvoMed Practitioner FB Group: https://bit.ly/2KpOfON
Health Advocates - Register to receive our newsletter: https://bit.ly/2vfggnj
The Evolution of Medicine is thrilled to announce its first forum on one of the most interesting, timely, and controversial topics in medicine: medical cannabis. At the genesis of the functional and integrative medicine movement in the 1960’s, there were a number of doctors who realized that cannabis was a powerful herb and had significant healing properties. This led to the further discussion of other herbs and other natural compounds that could affect health in a meaningful way. In this forum, we will look at all aspec...
published: 29 Nov 2017
-
Endocannabinoid System: A Fifty Year Trip - Raphael Mechoulam
Tags: Cannabinoids, Epilepsy, Physiological Effects, Endocannabinoid System
Raphael Mechoulam presents "Endocannabinoid System: A Fifty Year Trip" at CannMed 2017. Join us for CannMed 2018, taking place October 22-24, 2018 at the brand-new UCLA Luskin Conference Center. This industry-leading event will feature 7 expert panels and 31 presentations from Raphael Mechoulam, Ethan Russo, Bonni Goldstein, Dustin Sulak, Kevin McKernan, Staci Gruber, David Meiri, Jeff Chen and more. Learn more at www.cannmedevents.com.
published: 28 Sep 2018
-
Prof. Raphael Mechoulam - Medical Cannabis & Cancer
Prof. Raphael Mechoulam - Professor of Medicinal Chemistry at The Hebrew University of Jerusalem, Israel
published: 25 Apr 2017
-
Raphael Mechoulam Previews CannMed 2019 Keynote Presentation
We caught up with Professor Raphael Mechoulam at his lab in Israel to discuss the topic of his CannMed 2019 Keynote presentation, which will be delivered LIVE in Pasadena, CA September 23. Mechoulam and his team have successfully stabilized the acid forms of cannabinoids, which are potentially more potent than their neutral counterparts. At CannMed 2019, he will describe this work in more detail and share his vision for the future of cannabinoid acid research.
Purchase tickets to CannMed 2019 at cannmedevents.com/tickets
published: 20 Aug 2019
-
Research on Cannabinoids Over the Decades and What’s to Come - Raphael Mechoulam
Tags: Addiction, Cannabinoids, Endocannabinoid System
Over the last few decades research on the cannabinoids has gone through several distinct phases:
A. Research on plant cannabinoids [mostly on tetrahydrocannabinol (THC) and cannabidiol (CBD)].
B. Research on endogenous cannabinoids [mostly on anandamide and 2-arachidonoyl glycerol (2-AG)]
C. Research on endogenous anandamide-like endogenous fatty acid amides with amino acids and ethanol amines.
A. Plant cannabinoids. While many dozens of plant cannabinoids are known today, most research is still on THC and CBD. THC has been approved as a drug for enhancement of appetite, and is also used to prevent vomiting due to cancer chemotherapy. However of particular interest is CBD, which does not cause the typical cannabis psychoactivity, bu...
published: 02 Jan 2019
-
EPISODE #150 Cannabinoid Acids with Dr. Raphael Mechoulam, Professor of Medicinal Chemistry at The
This week is a special episode - our 150th! And we’re honoured to be celebrating this milestone by welcoming back Dr. Raphael Mechoulam to the show - ‘The Godfather of Cannabis Research'.
Together, we deep dive into Dr. Mechoulam's current work looking at cannabinoid acids - examining their role interacting with the endocannabinoid system, their manipulation into compounds, as well as discussing his latest research into endogenous cannabinoids.
The Cannabis Conversation is sponsored by Lumino - a boutique HR and Recruitment Agency specialising in building high performance teams for the European Cannabis Industry. They work in three main verticals: Commercial, Medical and Plant Facing.
Get in touch at: www.luminorecruit.com/
📚 VIEW SHOW NOTES AND EXTRAS:
https://www.canverse.global/...
published: 14 Feb 2022
-
Why Healthcare Professionals Should Attend CannMed | Raphael Mechoulam
Cannabis research pioneer, Dr. Raphael Mechoulam, explains that although there is more research to be done into the medical efficacy of cannabis, there is enough knowledge available for healthcare professionals to use cannabis to treat pain, epilepsy, and other conditions.
Scientific conferences, such as CannMed 2017, are critical components to expanding that knowledge so that cannabis can be appropriately used to help patients.
published: 06 Feb 2017
-
EPISODE #80 Interviewing the Godfather of Cannabis Research - Prof. Raphael Mechoulam
Where did modern cannabis research start?
This week we’re honoured and privileged to be joined by the legendary Professor Raphael Mechoulam - heading up the Medical Chemistry department at the Hebrew University of Jerusalem. Dubbed ‘the godfather of cannabis research', Prof. Mechoulam has been a pioneer in the field, and over many decades has had a major influence on our understanding of the cannabis plant with his groundbreaking research and discoveries.
In this very special episode of The Cannabis Conversation, we explore the history of cannabis research, alongside taking a detailed look at the function and physiology of the endocannabinoid system.
→ View full show notes and summary here: https://www.cannabis-conversation.com/blogs/episode80
About Prof. Mechoulam
Dr. Raphael Mechou...
published: 21 Sep 2020
-
The Cannabinoids: Looking Back and Ahead - Raphael Mechoulam
Tags: Cannabinoid Receptors, Endocannabinoid System, Compounds, Cannabinoids
published: 16 Dec 2020
45:28
21. Cannabis Research Past, Present, & Future with Raphael Mechoulam, PhD
Our latest guest is Professor Raphael Mechoulam. Professor Mechoulam is the first researcher to isolate THC and CBD. For that achievement and the decades of res...
Our latest guest is Professor Raphael Mechoulam. Professor Mechoulam is the first researcher to isolate THC and CBD. For that achievement and the decades of research into the endocannabinoid system that followed, Professor Mechoulam is often called the “Godfather of cannabis research”.
Since his research began in the 1960s, Professor Mechoulam has received numerous academic awards. Most recently he received The Harvey Prize from the Technion Israel Institute of Technology in the Human Health category. It’s a pretty big deal when you consider more than 30% of Harvey laureates since 1986 have gone onto receive the Nobel prize.
Professor Mechoulam has presented at every CannMed event, either in person or via submitted video, and is the chair of our Scientific Advisory Board.
In our conversation, we discuss:
Professor Mechoulam’s incredible career
The disappointing lack of cannabis medicine clinical trials
The surprising fact that the two major endogenous cannabinoids (anandamide and 2AG) have never been administered to humans
The challenge of researching the entourage effect
The benefits of cannabinoid acids
The newly discovered anandamide-like compounds that could be used to treat addiction
And more
Thanks to our Sponsor: Cannabis Science and Technology
Cannabis Science and Technology focuses on educating the legal cannabis industry about the science and technology of analytical testing, quality control/assurance, extraction, cultivation, and processing/manufacturing. In October Cannabis Science & Technology launched a new brand, Cannabis Patient Care, which is an educational resource for patients, doctors, nurses, pharmacists, and caregivers on the latest research, benefits, and treatment options cannabis provides for a variety of illnesses.
Learn more at cannabissciencetech.com
Additional Resources
Isolation and structure of a brain constituent that binds to the cannabinoid receptor (https://pubmed.ncbi.nlm.nih.gov/1470919/)
The chemistry of endocannabinoid (https://pubmed.ncbi.nlm.nih.gov/16751705/)
An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity (https://pubmed.ncbi.nlm.nih.gov/9721036/)
https://wn.com/21._Cannabis_Research_Past,_Present,_Future_With_Raphael_Mechoulam,_Phd
Our latest guest is Professor Raphael Mechoulam. Professor Mechoulam is the first researcher to isolate THC and CBD. For that achievement and the decades of research into the endocannabinoid system that followed, Professor Mechoulam is often called the “Godfather of cannabis research”.
Since his research began in the 1960s, Professor Mechoulam has received numerous academic awards. Most recently he received The Harvey Prize from the Technion Israel Institute of Technology in the Human Health category. It’s a pretty big deal when you consider more than 30% of Harvey laureates since 1986 have gone onto receive the Nobel prize.
Professor Mechoulam has presented at every CannMed event, either in person or via submitted video, and is the chair of our Scientific Advisory Board.
In our conversation, we discuss:
Professor Mechoulam’s incredible career
The disappointing lack of cannabis medicine clinical trials
The surprising fact that the two major endogenous cannabinoids (anandamide and 2AG) have never been administered to humans
The challenge of researching the entourage effect
The benefits of cannabinoid acids
The newly discovered anandamide-like compounds that could be used to treat addiction
And more
Thanks to our Sponsor: Cannabis Science and Technology
Cannabis Science and Technology focuses on educating the legal cannabis industry about the science and technology of analytical testing, quality control/assurance, extraction, cultivation, and processing/manufacturing. In October Cannabis Science & Technology launched a new brand, Cannabis Patient Care, which is an educational resource for patients, doctors, nurses, pharmacists, and caregivers on the latest research, benefits, and treatment options cannabis provides for a variety of illnesses.
Learn more at cannabissciencetech.com
Additional Resources
Isolation and structure of a brain constituent that binds to the cannabinoid receptor (https://pubmed.ncbi.nlm.nih.gov/1470919/)
The chemistry of endocannabinoid (https://pubmed.ncbi.nlm.nih.gov/16751705/)
An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity (https://pubmed.ncbi.nlm.nih.gov/9721036/)
- published: 03 Feb 2021
- views: 2285
12:12
Functional Forum Interview: Medical Cannabis with Dr. Raphael Mechoulam
Register to watch next the Functional Forum: http://functionalforum.com/next-event
Subscribe: https://bit.ly/2n9QpsC
Practitioners - Join the EvoMed Practitione...
Register to watch next the Functional Forum: http://functionalforum.com/next-event
Subscribe: https://bit.ly/2n9QpsC
Practitioners - Join the EvoMed Practitioner FB Group: https://bit.ly/2KpOfON
Health Advocates - Register to receive our newsletter: https://bit.ly/2vfggnj
The Evolution of Medicine is thrilled to announce its first forum on one of the most interesting, timely, and controversial topics in medicine: medical cannabis. At the genesis of the functional and integrative medicine movement in the 1960’s, there were a number of doctors who realized that cannabis was a powerful herb and had significant healing properties. This led to the further discussion of other herbs and other natural compounds that could affect health in a meaningful way. In this forum, we will look at all aspects to do with medical cannabis. This information is useful whether you are in America or in any other country around the world. We look forward to a really exciting forum.
Our first keynote speaker is Raphael Mechoulam, Ph.D. Dr. Mechoulam is a pioneer in the field of cannabis research and the godfather of research into the endocannabinoid system. He is an organic chemist and professor of medicinal chemistry at the Hebrew University of Jerusalem in Israel.
Contact us:
[email protected]
https://wn.com/Functional_Forum_Interview_Medical_Cannabis_With_Dr._Raphael_Mechoulam
Register to watch next the Functional Forum: http://functionalforum.com/next-event
Subscribe: https://bit.ly/2n9QpsC
Practitioners - Join the EvoMed Practitioner FB Group: https://bit.ly/2KpOfON
Health Advocates - Register to receive our newsletter: https://bit.ly/2vfggnj
The Evolution of Medicine is thrilled to announce its first forum on one of the most interesting, timely, and controversial topics in medicine: medical cannabis. At the genesis of the functional and integrative medicine movement in the 1960’s, there were a number of doctors who realized that cannabis was a powerful herb and had significant healing properties. This led to the further discussion of other herbs and other natural compounds that could affect health in a meaningful way. In this forum, we will look at all aspects to do with medical cannabis. This information is useful whether you are in America or in any other country around the world. We look forward to a really exciting forum.
Our first keynote speaker is Raphael Mechoulam, Ph.D. Dr. Mechoulam is a pioneer in the field of cannabis research and the godfather of research into the endocannabinoid system. He is an organic chemist and professor of medicinal chemistry at the Hebrew University of Jerusalem in Israel.
Contact us:
[email protected]
- published: 29 Nov 2017
- views: 1807
27:51
Endocannabinoid System: A Fifty Year Trip - Raphael Mechoulam
Tags: Cannabinoids, Epilepsy, Physiological Effects, Endocannabinoid System
Raphael Mechoulam presents "Endocannabinoid System: A Fifty Year Trip" at CannMed 2...
Tags: Cannabinoids, Epilepsy, Physiological Effects, Endocannabinoid System
Raphael Mechoulam presents "Endocannabinoid System: A Fifty Year Trip" at CannMed 2017. Join us for CannMed 2018, taking place October 22-24, 2018 at the brand-new UCLA Luskin Conference Center. This industry-leading event will feature 7 expert panels and 31 presentations from Raphael Mechoulam, Ethan Russo, Bonni Goldstein, Dustin Sulak, Kevin McKernan, Staci Gruber, David Meiri, Jeff Chen and more. Learn more at www.cannmedevents.com.
https://wn.com/Endocannabinoid_System_A_Fifty_Year_Trip_Raphael_Mechoulam
Tags: Cannabinoids, Epilepsy, Physiological Effects, Endocannabinoid System
Raphael Mechoulam presents "Endocannabinoid System: A Fifty Year Trip" at CannMed 2017. Join us for CannMed 2018, taking place October 22-24, 2018 at the brand-new UCLA Luskin Conference Center. This industry-leading event will feature 7 expert panels and 31 presentations from Raphael Mechoulam, Ethan Russo, Bonni Goldstein, Dustin Sulak, Kevin McKernan, Staci Gruber, David Meiri, Jeff Chen and more. Learn more at www.cannmedevents.com.
- published: 28 Sep 2018
- views: 38154
4:39
Prof. Raphael Mechoulam - Medical Cannabis & Cancer
Prof. Raphael Mechoulam - Professor of Medicinal Chemistry at The Hebrew University of Jerusalem, Israel
Prof. Raphael Mechoulam - Professor of Medicinal Chemistry at The Hebrew University of Jerusalem, Israel
https://wn.com/Prof._Raphael_Mechoulam_Medical_Cannabis_Cancer
Prof. Raphael Mechoulam - Professor of Medicinal Chemistry at The Hebrew University of Jerusalem, Israel
- published: 25 Apr 2017
- views: 4380
2:23
Raphael Mechoulam Previews CannMed 2019 Keynote Presentation
We caught up with Professor Raphael Mechoulam at his lab in Israel to discuss the topic of his CannMed 2019 Keynote presentation, which will be delivered LIVE i...
We caught up with Professor Raphael Mechoulam at his lab in Israel to discuss the topic of his CannMed 2019 Keynote presentation, which will be delivered LIVE in Pasadena, CA September 23. Mechoulam and his team have successfully stabilized the acid forms of cannabinoids, which are potentially more potent than their neutral counterparts. At CannMed 2019, he will describe this work in more detail and share his vision for the future of cannabinoid acid research.
Purchase tickets to CannMed 2019 at cannmedevents.com/tickets
https://wn.com/Raphael_Mechoulam_Previews_Cannmed_2019_Keynote_Presentation
We caught up with Professor Raphael Mechoulam at his lab in Israel to discuss the topic of his CannMed 2019 Keynote presentation, which will be delivered LIVE in Pasadena, CA September 23. Mechoulam and his team have successfully stabilized the acid forms of cannabinoids, which are potentially more potent than their neutral counterparts. At CannMed 2019, he will describe this work in more detail and share his vision for the future of cannabinoid acid research.
Purchase tickets to CannMed 2019 at cannmedevents.com/tickets
- published: 20 Aug 2019
- views: 2954
32:47
Research on Cannabinoids Over the Decades and What’s to Come - Raphael Mechoulam
Tags: Addiction, Cannabinoids, Endocannabinoid System
Over the last few decades research on the cannabinoids has gone through several distinct phases:
A. Rese...
Tags: Addiction, Cannabinoids, Endocannabinoid System
Over the last few decades research on the cannabinoids has gone through several distinct phases:
A. Research on plant cannabinoids [mostly on tetrahydrocannabinol (THC) and cannabidiol (CBD)].
B. Research on endogenous cannabinoids [mostly on anandamide and 2-arachidonoyl glycerol (2-AG)]
C. Research on endogenous anandamide-like endogenous fatty acid amides with amino acids and ethanol amines.
A. Plant cannabinoids. While many dozens of plant cannabinoids are known today, most research is still on THC and CBD. THC has been approved as a drug for enhancement of appetite, and is also used to prevent vomiting due to cancer chemotherapy. However of particular interest is CBD, which does not cause the typical cannabis psychoactivity, but is a potent anti- epileptic drug and is used in many countries in pediatric epilepsy. It is being evaluated in other therapeutic areas (graft versus host disease, schizophrenia, autoimmune diseases).
B. Endogenous cannabinoids. The endogenous cannabinoids anandamide and 2-arachidonoyl glycerol (2-AG) were discovered in the 1990’s. Both compounds bind to the cannabinoid receptors CB1 and CB2. They are involved in a very large number of diseases, mostly as neuroprotective entities. However neither anandamide nor 2-AG have been administered to humans and although they are highly promising as potential drugs clinical trials have to be undertaken.
C. Anandamide-like endogenous fatty acid amides with amino acids and ethanol amines. A large number of compounds of these types have been discovered in the brain and other tissues, and some of them have been shown to be of major importance in a large spectrum of biological functions and diseases. Thus, oleoyl serine is an anti-osteoporotic molecule, arachidonoyl serine is a vasodilator and lowers brain damage and oleoyl glycine has anti addiction properties.
https://wn.com/Research_On_Cannabinoids_Over_The_Decades_And_What’S_To_Come_Raphael_Mechoulam
Tags: Addiction, Cannabinoids, Endocannabinoid System
Over the last few decades research on the cannabinoids has gone through several distinct phases:
A. Research on plant cannabinoids [mostly on tetrahydrocannabinol (THC) and cannabidiol (CBD)].
B. Research on endogenous cannabinoids [mostly on anandamide and 2-arachidonoyl glycerol (2-AG)]
C. Research on endogenous anandamide-like endogenous fatty acid amides with amino acids and ethanol amines.
A. Plant cannabinoids. While many dozens of plant cannabinoids are known today, most research is still on THC and CBD. THC has been approved as a drug for enhancement of appetite, and is also used to prevent vomiting due to cancer chemotherapy. However of particular interest is CBD, which does not cause the typical cannabis psychoactivity, but is a potent anti- epileptic drug and is used in many countries in pediatric epilepsy. It is being evaluated in other therapeutic areas (graft versus host disease, schizophrenia, autoimmune diseases).
B. Endogenous cannabinoids. The endogenous cannabinoids anandamide and 2-arachidonoyl glycerol (2-AG) were discovered in the 1990’s. Both compounds bind to the cannabinoid receptors CB1 and CB2. They are involved in a very large number of diseases, mostly as neuroprotective entities. However neither anandamide nor 2-AG have been administered to humans and although they are highly promising as potential drugs clinical trials have to be undertaken.
C. Anandamide-like endogenous fatty acid amides with amino acids and ethanol amines. A large number of compounds of these types have been discovered in the brain and other tissues, and some of them have been shown to be of major importance in a large spectrum of biological functions and diseases. Thus, oleoyl serine is an anti-osteoporotic molecule, arachidonoyl serine is a vasodilator and lowers brain damage and oleoyl glycine has anti addiction properties.
- published: 02 Jan 2019
- views: 29742
36:55
EPISODE #150 Cannabinoid Acids with Dr. Raphael Mechoulam, Professor of Medicinal Chemistry at The
This week is a special episode - our 150th! And we’re honoured to be celebrating this milestone by welcoming back Dr. Raphael Mechoulam to the show - ‘The Godf...
This week is a special episode - our 150th! And we’re honoured to be celebrating this milestone by welcoming back Dr. Raphael Mechoulam to the show - ‘The Godfather of Cannabis Research'.
Together, we deep dive into Dr. Mechoulam's current work looking at cannabinoid acids - examining their role interacting with the endocannabinoid system, their manipulation into compounds, as well as discussing his latest research into endogenous cannabinoids.
The Cannabis Conversation is sponsored by Lumino - a boutique HR and Recruitment Agency specialising in building high performance teams for the European Cannabis Industry. They work in three main verticals: Commercial, Medical and Plant Facing.
Get in touch at: www.luminorecruit.com/
📚 VIEW SHOW NOTES AND EXTRAS:
https://www.canverse.global/shownotes/e150
About Dr. Raphael Mechoulam
Dr. Raphael Mechoulam is an award-winning Israeli organic chemist who has been studying the cannabis plant for over 50 years. Dr. Mechoulam is best known for discovering the Endocannabinoid System and first isolating the two primary compounds, CBD and THC. He is a professor of Medicinal Chemistry at the Hebrew University of Jerusalem in Israel and has published over 350 scientific articles, primarily focused on the chemistry and pharmacology of Cannabinoids. His work has awarded him with many honors and awards, including the Israel Prize (2000), NIDA Discovery Award (2011) and many others.
Quotables
“I hope that people will look at cannabis research as a positive thing, and I hope that it brings us an additional understanding of what our body does”
Resources
Dr. Mechoulam’s Wikipedia Page: https://en.wikipedia.org/wiki/Raphael_Mechoulam
Dr. Mechoulam’s papers on Google Scholar: https://scholar.google.co.uk/citations?user=err5l-YAAAAJ&hl=en
The Multidisciplinary Center for Cannabinoid Research’s Website: https://cannabinoids.huji.ac.il/
https://wn.com/Episode_150_Cannabinoid_Acids_With_Dr._Raphael_Mechoulam,_Professor_Of_Medicinal_Chemistry_At_The
This week is a special episode - our 150th! And we’re honoured to be celebrating this milestone by welcoming back Dr. Raphael Mechoulam to the show - ‘The Godfather of Cannabis Research'.
Together, we deep dive into Dr. Mechoulam's current work looking at cannabinoid acids - examining their role interacting with the endocannabinoid system, their manipulation into compounds, as well as discussing his latest research into endogenous cannabinoids.
The Cannabis Conversation is sponsored by Lumino - a boutique HR and Recruitment Agency specialising in building high performance teams for the European Cannabis Industry. They work in three main verticals: Commercial, Medical and Plant Facing.
Get in touch at: www.luminorecruit.com/
📚 VIEW SHOW NOTES AND EXTRAS:
https://www.canverse.global/shownotes/e150
About Dr. Raphael Mechoulam
Dr. Raphael Mechoulam is an award-winning Israeli organic chemist who has been studying the cannabis plant for over 50 years. Dr. Mechoulam is best known for discovering the Endocannabinoid System and first isolating the two primary compounds, CBD and THC. He is a professor of Medicinal Chemistry at the Hebrew University of Jerusalem in Israel and has published over 350 scientific articles, primarily focused on the chemistry and pharmacology of Cannabinoids. His work has awarded him with many honors and awards, including the Israel Prize (2000), NIDA Discovery Award (2011) and many others.
Quotables
“I hope that people will look at cannabis research as a positive thing, and I hope that it brings us an additional understanding of what our body does”
Resources
Dr. Mechoulam’s Wikipedia Page: https://en.wikipedia.org/wiki/Raphael_Mechoulam
Dr. Mechoulam’s papers on Google Scholar: https://scholar.google.co.uk/citations?user=err5l-YAAAAJ&hl=en
The Multidisciplinary Center for Cannabinoid Research’s Website: https://cannabinoids.huji.ac.il/
- published: 14 Feb 2022
- views: 2186
1:30
Why Healthcare Professionals Should Attend CannMed | Raphael Mechoulam
Cannabis research pioneer, Dr. Raphael Mechoulam, explains that although there is more research to be done into the medical efficacy of cannabis, there is enoug...
Cannabis research pioneer, Dr. Raphael Mechoulam, explains that although there is more research to be done into the medical efficacy of cannabis, there is enough knowledge available for healthcare professionals to use cannabis to treat pain, epilepsy, and other conditions.
Scientific conferences, such as CannMed 2017, are critical components to expanding that knowledge so that cannabis can be appropriately used to help patients.
https://wn.com/Why_Healthcare_Professionals_Should_Attend_Cannmed_|_Raphael_Mechoulam
Cannabis research pioneer, Dr. Raphael Mechoulam, explains that although there is more research to be done into the medical efficacy of cannabis, there is enough knowledge available for healthcare professionals to use cannabis to treat pain, epilepsy, and other conditions.
Scientific conferences, such as CannMed 2017, are critical components to expanding that knowledge so that cannabis can be appropriately used to help patients.
- published: 06 Feb 2017
- views: 287
40:35
EPISODE #80 Interviewing the Godfather of Cannabis Research - Prof. Raphael Mechoulam
Where did modern cannabis research start?
This week we’re honoured and privileged to be joined by the legendary Professor Raphael Mechoulam - heading up the Me...
Where did modern cannabis research start?
This week we’re honoured and privileged to be joined by the legendary Professor Raphael Mechoulam - heading up the Medical Chemistry department at the Hebrew University of Jerusalem. Dubbed ‘the godfather of cannabis research', Prof. Mechoulam has been a pioneer in the field, and over many decades has had a major influence on our understanding of the cannabis plant with his groundbreaking research and discoveries.
In this very special episode of The Cannabis Conversation, we explore the history of cannabis research, alongside taking a detailed look at the function and physiology of the endocannabinoid system.
→ View full show notes and summary here: https://www.cannabis-conversation.com/blogs/episode80
About Prof. Mechoulam
Dr. Raphael Mechoulam is an award-winning Israeli organic chemist who has been studying the cannabis plant for over 50 years. Dr. Mechoulam is best known for discovering the Endocannabinoid System and first isolating the two primary compounds, CBD and THC. He is a professor of Medicinal Chemistry at the Hebrew University of Jerusalem in Israel and has published over 350 scientific articles, primarily focused on the chemistry and pharmacology of Cannabinoids. His work has awarded him with many honors and awards, including the Israel Prize (2000), NIDA Discovery Award (2011) and many others.
Resources
Prof. Raphael Mechoulam’s Wikipedia Page: https://en.wikipedia.org/wiki/Raphael_Mechoulam
‘Dr Raphael Mechoulam and his revolutionary cannabis research’ - Article by Medical Cannabis Network:
https://www.healtheuropa.eu/dr-raphael-mechoulam-revolutionary-cannabis-research/93049/
‘Cannabinoid pharmacology: the first 66 years’ paper by Roger G Pertwee: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1760722/
https://wn.com/Episode_80_Interviewing_The_Godfather_Of_Cannabis_Research_Prof._Raphael_Mechoulam
Where did modern cannabis research start?
This week we’re honoured and privileged to be joined by the legendary Professor Raphael Mechoulam - heading up the Medical Chemistry department at the Hebrew University of Jerusalem. Dubbed ‘the godfather of cannabis research', Prof. Mechoulam has been a pioneer in the field, and over many decades has had a major influence on our understanding of the cannabis plant with his groundbreaking research and discoveries.
In this very special episode of The Cannabis Conversation, we explore the history of cannabis research, alongside taking a detailed look at the function and physiology of the endocannabinoid system.
→ View full show notes and summary here: https://www.cannabis-conversation.com/blogs/episode80
About Prof. Mechoulam
Dr. Raphael Mechoulam is an award-winning Israeli organic chemist who has been studying the cannabis plant for over 50 years. Dr. Mechoulam is best known for discovering the Endocannabinoid System and first isolating the two primary compounds, CBD and THC. He is a professor of Medicinal Chemistry at the Hebrew University of Jerusalem in Israel and has published over 350 scientific articles, primarily focused on the chemistry and pharmacology of Cannabinoids. His work has awarded him with many honors and awards, including the Israel Prize (2000), NIDA Discovery Award (2011) and many others.
Resources
Prof. Raphael Mechoulam’s Wikipedia Page: https://en.wikipedia.org/wiki/Raphael_Mechoulam
‘Dr Raphael Mechoulam and his revolutionary cannabis research’ - Article by Medical Cannabis Network:
https://www.healtheuropa.eu/dr-raphael-mechoulam-revolutionary-cannabis-research/93049/
‘Cannabinoid pharmacology: the first 66 years’ paper by Roger G Pertwee: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1760722/
- published: 21 Sep 2020
- views: 5401
1:02:26
The Cannabinoids: Looking Back and Ahead - Raphael Mechoulam
Tags: Cannabinoid Receptors, Endocannabinoid System, Compounds, Cannabinoids
Tags: Cannabinoid Receptors, Endocannabinoid System, Compounds, Cannabinoids
https://wn.com/The_Cannabinoids_Looking_Back_And_Ahead_Raphael_Mechoulam
Tags: Cannabinoid Receptors, Endocannabinoid System, Compounds, Cannabinoids
- published: 16 Dec 2020
- views: 3629